CERS(Cerus Corporation) · 财务报表

CERS(Cerus Corporation) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$159.52M$188.31M$186.80M$201.32M$233.80M
毛利润—————
营业利润−$48.94M−$34.08M−$30.05M−$14.22M−$8.68M
净利润−$54.37M−$42.78M−$37.49M−$20.92M−$15.63M
经营现金流−$33.92M−$25.61M−$43.17M$11.36M$4.84M
自由现金流−$34.83M−$27.61M−$47.77M$8.52M$1.11M
摊薄每股收益$-0.32$-0.24$-0.21$-0.11$-0.08

Cerus Corporation CERS